MedPath
NMPA Approval

Denosumab Injection

国药准字S20240010

July 31, 2024

Drug Information

地舒单抗注射液

迈卫健

注射剂

120mg(1.7ml)/瓶

生物制品

July 31, 2024

Company Information

Applicant Company

泰州市药城大道1号G03幢厂房

Manufacturing Company

泰州市健康大道803号G55幢

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

地舒单抗注射液 - NMPA 批准文号 | MedPath